Failed to locate the main schema resource at 'http://schema.datacite.org/meta/kernel-4/metadata.xsd'.
<?xml version="1.0" encoding="utf-8"?> <resource xmlns="http://datacite.org/schema/kernel-4" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4/metadata.xsd"> <identifier identifierType="DOI">10.30834/KJP.37.2.2024.477.</identifier> <creators> <creator> <creatorName>PM, Lakshmipriya</creatorName> </creator> <creator> <creatorName>Tharayil, Harish M</creatorName> </creator> <creator> <creatorName>K, Ramash</creatorName> </creator> <creator> <creatorName>Varsha VIdhyadaran</creatorName> </creator> <creator> <creatorName>Afeefa Moidu</creatorName> </creator> </creators> <titles> <title>Recurrent Treatment Emergent Delirium in A Case Of Bipolar Disorder With Primary Adrenal Insufficiency- A Case Report</title> </titles> <publisher>Kerala Journal of Psychiatry </publisher> <publicationYear>2024</publicationYear> <dates> <date dateType="Submitted">2024-10-09</date> <date dateType="Accepted">2024-11-01</date> <date dateType="Updated">2024-11-09</date> <date dateType="Issued">2024-11-01</date> </dates> <language>en</language> <resourceType resourceTypeGeneral="Text">Article</resourceType> <alternateIdentifiers> <alternateIdentifier alternateIdentifierType="publisherId">1-28-477</alternateIdentifier> </alternateIdentifiers> <rightsList> <rights rightsURI="https://creativecommons.org/licenses/by-nc/4.0">This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</rights> </rightsList> <descriptions> <description descriptionType="Abstract"> Background: Addison’s disease (AD) is associated with a range of neuropsychiatric symptoms, including mood disorders. Treatment-emergent delirium in patients with AD and comorbid bipolar affective disorder (BPAD) is rare. Case Report: A 45-year-old male with a 25-year history of episodic psychiatric illness developed increased talkativeness, overfamiliarity, and decreased need for sleep after medication discontinuation. Upon readmission, he was treated with lithium, quetiapine, and sodium valproate, subsequently developing delirium and hyponatremia. Sodium valproate was discontinued, and low-dose antipsychotics were introduced alongside lithium adjustments. He responded well, with delirium resolving and manic symptoms managed effectively. Discussion: This case underscores the need for careful monitoring of electrolyte levels in patients with AD on psychotropic medications to prevent treatment-emergent delirium. </description> <description descriptionType="SeriesInformation">Kerala Journal of Psychiatry , Ahead of print</description> </descriptions> </resource>